# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615117 | B | The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM | 1 | assay format | Scientific Literature | |||
2. | ALA615118 | F | Compound was evaluated for its ability to mobilize calcium in 1321NI cells | 1 | cell-based format | Scientific Literature | |||
3. | ALA615119 | B | ⋯ | assay format | Scientific Literature | ||||
4. | ALA615120 | B | Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680 | Bos taurus | 1 | cell membrane format | Scientific Literature | ||
5. | ALA615121 | F | In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line) | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
6. | ALA615122 | F | In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line) | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
7. | ALA615123 | F | Cytotoxic Activity was evaluated against 143B (TK-) tumor cells | Mus musculus | 2 | cell-based format | Scientific Literature | ||
8. | ALA615124 | F | In vitro cell cytotoxicity was determined against 143B cell line | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
9. | ALA615125 | F | Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
10. | ALA615126 | F | In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
11. | ALA615127 | F | In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
12. | ALA615128 | F | In vitro cell cytotoxicity was determined against 143B-LTK cell line | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
13. | ALA857900 | F | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | Staphylococcus aureus | 1 | organism-based format | Scientific Literature | ||
14. | ALA615129 | F | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
15. | ALA615130 | F | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | Staphylococcus aureus | 14 | organism-based format | Scientific Literature | ||
16. | ALA615131 | F | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | Staphylococcus aureus | 1 | organism-based format | Scientific Literature | ||
17. | ALA884521 | A | Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase | Rattus norvegicus | 3 | single protein format | Scientific Literature | ||
18. | ALA615132 | B | Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO) | 5 | single protein format | Scientific Literature | |||
19. | ALA615133 | B | Inhibition of partially purified 15-lipoxygenase from human leukocytes | 1 | assay format | Scientific Literature | |||
20. | ALA615134 | B | Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO) | 9 | single protein format | Scientific Literature |